Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9Unspecified Adult Solid Tumor, Protocol Specific 2Sarcoma 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostatic Diseases 1Pancreatic Neoplasms 1Pain 1Non-squamous Non-small Cell Lung Cancer 1Neoplasms, Glandular and Epithelial 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Genital Neoplasms, Male 1Genital Diseases, Male 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms, Male 1Bile Duct Neoplasms 1Advanced Solid Tumors 1Adenocarcinoma 1

Interventions

Sunitinib 2pembrolizumab 1palbociclib 1linifanib 1ixabepilone 1VB6-845 fusion protein 1Taxes 1Sorafenib 1Papanicolaou Test 1Human Papillomavirus DNA Tests 1Gemcitabine 1Colposcopy 1Cobicistat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms, Glandular and Epithelial × ixabepilone × Clear all
NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Cedars-Sinai Medical Center

Phase 2 Terminated
11 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡